Contact Us | Print Page | Sign In | Register
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 8 of 10
 |<   <<   <  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10

Industry News for MS (INforMS)
Tuesday, February 9, 2016
CMSC INforMS: MS Patients Seen to Safely Switch to Oral Drugs from Injectable Oral Therapies »
Stable multiple sclerosis (MS) patients do not appear to be at any increased risk of disease reactivation while switc...
Saturday, February 6, 2016
CMSC INforMS: Adaptive Yoga for Multiple Sclerosis »
Some people with multiple sclerosis decide to avoid yoga because they believe they won’t be able to do the poses or may fe...
Monday, February 1, 2016
CMSC INforMS: New MRI technique offers faster diagnosis of multiple sclerosis »
A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by re...
Friday, January 29, 2016
CMSC INforMS: Beyond First-Line: Natalizumab vs Fingolimod for Relapsing-Remitting MS »
For patients with multiple sclerosis (MS) who are treated with injectable disease-modifying therapies (DMTs) for more than...
Tuesday, January 26, 2016
CMSC INforMS: Study details source of mental problems associated with multiple sclerosis »
A study out today sheds new light on multiple sclerosis (MS), specifically damage in the brain caused by the disease that...
Monday, January 25, 2016
CMSC INforMS: Epilepsy drug 'could help multiple sclerosis patients' »
An anti-convulsant drug used to treat epilepsy may also prevent nerve damage in patients with multiple sclerosis (MS), res...
Monday, January 25, 2016
CMSC INforMS: No Early Risk When Stable MS Patients Switch to Oral Drugs »
No differences in relapse or progression rates between switchers & stayers over 6 months Multiple sclerosis patien...
Tuesday, January 19, 2016
CMSC INforMS: Multiple Sclerosis (MS) Patients Showing Progress With Cancer Treatment »
The doctors in Sheffield England discovered that the treatment normally used for cancer patients has worked well with peop...
Friday, January 15, 2016
CMSC INforMS: Obstructive sleep apnea, sleep disorders may contribute to multiple sclerosis fatigue »
Obstructive sleep apnea (OSA) and sleep disorders may contribute to multiple sclerosis fatigue. Sleep problems and lack of...
Tuesday, January 12, 2016
CMSC INforMS: Suppressing Immune Disorders in Multiple Sclerosis »
There may be an easy way to treat immune related disorders in mice models of multiple sclerosis (MS), according to a stud...
Friday, January 8, 2016
CMSC INforMS: Multiple sclerosis occurrence in women three to four times more likely than men »
Occurrence of multiple sclerosis in women is three to four times higher compared to men. Multiple sclerosis (MS) in women...
Thursday, January 7, 2016
CMSC INforMS: Multiple sclerosis bladder control problems include incontinence and nocturia »
Multiple sclerosis can cause bladder control problems like incontinence and nocturia. Bladder control problems are actuall...
Tuesday, January 5, 2016
CMSC INforMS: Multiple sclerosis eye problems: Optic neuritis, nystagmus and diplopia »
Multiple sclerosis (MS) can lead to many health complications including eye problems like optic neuritis, nystagmus and di...
Monday, January 4, 2016
CMSC INforMS: Multiple Sclerosis Clinical Trials More Successful Than Other Diseases »
Clinical trials for multiple sclerosis (MS) therapies demonstrate a success rate that is nearly triple that of other disea...
Monday, January 4, 2016
CMSC INforMS: High dose vitamin D could treat multiple sclerosis, scientists find »
Low levels of vitamin D are known to be associated with an increased risk of developing MS but it is the first study to sh...
Monday, December 21, 2015
CMSC INforMS: Can We Vaccinate Against PML in Multiple Sclerosis? »
“Both active vaccination/treatment with major capsid protein VP1 of JC polyoma virus and passive vaccination/treatment wit...
Friday, December 18, 2015
CMSC INforMS: Brain Cell Death May Cause Multiple Sclerosis »
Scientists say they’ve pinpointed the brain cell deaths that seem to trigger MS, and their research could lead to a new tr...
Thursday, December 17, 2015
CMSC INforMS: New Drug Is First to Treat Progressive Multiple Sclerosis »
Studies show that ocrelizumab works for both the relapsing and progressive forms of MS. Symptoms come and go in mos...
Tuesday, December 15, 2015
CMSC INforMS: Neuronal Death Is Possible Onset Source of Multiple Sclerosis »
The initial trigger for the development of multiple sclerosis (MS) has eluded scientists for decades. Theories have ranged...
Monday, December 14, 2015
CMSC INforMS: How multiple sclerosis can be triggered by brain cell death »
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surpr...
Friday, December 11, 2015
CMSC INforMS: Multiple sclerosis paroxysmal symptoms confused with seizures due to sudden onset »
Multiple sclerosis paroxysmal symptoms can be confused with seizures due to its sudden onset. Paroxysmal symptoms are uniq...
Thursday, December 10, 2015
CMSC INforMS: How Vitamin D Repairs Myelin in Multiple Sclerosis »
An international team of researchers have proposed how vitamin D repairs myelin in multiple sclerosis. This finding could...
Wednesday, December 9, 2015
CMSC INforMS: Poor Visual Symptoms in Multiple Sclerosis Patients »
Multiple sclerosis (MS) patients with histories of neuro-ophthalmic symptoms performed poorly on neuropsychological tasks,...
Tuesday, December 8, 2015
CMSC INforMS: Multiple sclerosis and the prevalence of sleep disorders, epileptic seizures »
Sleep disorders and epileptic seizures are of higher prevalence in those with multiple sclerosis.  Multiple sclerosis...
Monday, December 7, 2015
CMSC INforMS: Cellular Target Opens New Pathway For Multiple Sclerosis Therapy »
MedicalResearch.com Interview with: Dr. Vittorio Gallo PhD Center for Neuroscience Research Children’s Research...
Saturday, December 5, 2015
CMSC INforMS: Multiple sclerosis causes psychiatric symptoms »
As a chronic neurological condition, it should come as no surprise that  multiple sclerosis  can  produce p...
Wednesday, December 2, 2015   (0 Comments - view/add)
CMSC INforMS: Pregnancy hormone could keep multiple sclerosis at bay »
Women taking a form of estrogen had fewer relapses BY   LAURA SANDERS   3:21PM, DECEMBER...
Wednesday, December 2, 2015
CMSC INforMS: MedDay misses endpoint in PhIII multiple sclerosis vision loss trial »
A Phase III trial of MedDay's  multiple sclerosis   drug has missed its primary endpoint. The drug, which made...
Tuesday, December 1, 2015
CMSC INforMS: Trigeminal neuralgia, type of nerve pain, is an early multiple sclerosis symptom »
A type of nerve pain, called trigeminal neuralgia, can be very hard to cope with and has become known as an   earl...
Tuesday, December 1, 2015
CMSC INforMS: Exploring new paths for the treatment of multiple sclerosis »
(Edmonton) Research from the University of Alberta's Faculty of Medicine & Dentistry is trailblazing a potential new p...
Wednesday, October 21, 2015   (0 Comments - view/add)
CMSC INforMS: Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in SPMS »
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS ASCEND Phase 3 T...
Monday, October 12, 2015   (0 Comments - view/add)
CMSC INforMS: EMD Serono announces publication of PRISMS-15yr follow-up study using Rebif in RRMS »
EMD Serono announces publication of PRISMS-15 yr follow-up study in patients using Rebif® (interferon beta-1a), focuse...
Thursday, October 8, 2015   (0 Comments - view/add)
CMSC INforMS: Treatment Effects Maintained Over 5 Years in Patients with RRMS who Received Lemtrada »
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Recei...
Thursday, October 8, 2015   (0 Comments - view/add)
CMSC INforMS: Genentech’s Ocrelizumab Show Positive Pivotal Study Results in Both RRMS and PPMS »
Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primar...
Thursday, October 8, 2015   (0 Comments - view/add)
CMSC INforMS: EMD Serono Announces Recipients of the Third Annual €1 Million Grant for MS Innovation »
EMD Serono Announces Recipients of the Third Annual €1 Million Grant for Multiple Sclerosis Innovation Four resea...

Displaying page 8 of 10
 |<   <<   <  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org